Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8900554 | LEO PHARMA AS | Foamable composition and uses thereof |
Oct, 2023
(5 months ago) | |
US10322085 | LEO PHARMA AS | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
Oct, 2023
(5 months ago) | |
US8722021 | LEO PHARMA AS | Foamable carriers |
Oct, 2023
(5 months ago) | |
US8435498 | LEO PHARMA AS | Penetrating pharmaceutical foam |
Mar, 2024
(27 days ago) | |
US7700076 | LEO PHARMA AS | Penetrating pharmaceutical foam |
Sep, 2027
(3 years from now) | |
US10117812 | LEO PHARMA AS | Foamable composition combining a polar solvent and a hydrophobic carrier |
Oct, 2027
(3 years from now) | |
US9265725 | LEO PHARMA AS | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
Dec, 2027
(3 years from now) | |
US9211259 | LEO PHARMA AS | Antibiotic kit and composition and uses thereof |
Feb, 2029
(4 years from now) |
Market Authorisation Date: 29 July, 2015
Treatment: Topical treatment of inflammatory papules and pustules of mild to moderate rosacea
Dosage: AEROSOL, FOAM;TOPICAL